Reply to “Serum Neurofilaments as Candidate Biomarkers of Natalizumab Progressive Multifocal Leukoencephalopathy”
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Neurology"
DOI: 10.1002/ana.25526
Abstract: In our recently published study we found that at the onset of PML serum NfL were 10-fold higher than in the pre-PML condition and in natalizumab-treated or untreated MS patients. The findings by Loonstra et… read more here.
Keywords: reply serum; biomarkers natalizumab; serum neurofilaments; candidate biomarkers ... See more keywords